5-Amino-1MQ (10 mg Vial) Dosage Protocol
5-Amino-1MQ dosage chart for the 10 mg Vial: typical dose 2.5 mg–5 mg daily, reconstitution to 5 mg/mL, and protocol. For research use only.
View protocolProtocol directory
Browse single peptides, blends, and stacks. Every public protocol is educational and research-only, with no product sale flow.
110
Total protocols
95
Single peptides
11
Blends
4
Stacks
5-Amino-1MQ dosage chart for the 10 mg Vial: typical dose 2.5 mg–5 mg daily, reconstitution to 5 mg/mL, and protocol. For research use only.
View protocol5-Amino-1MQ dosage chart for the 50 mg Vial: typical dose 2.5 mg–5 mg daily, reconstitution to 12.5 mg/mL, and protocol. For research use only.
View protocolAdamax dosage chart for the 10 mg Vial: typical dose 300 mcg–1 mg daily, reconstitution to 3.33 mg/mL, injection frequency, and protocol. For research use only.
View protocolAdipotide dosage chart for the 10 mg Vial: typical dose 250 mcg–1 mg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolAICAR dosage chart for the 50 mg Vial: typical dose 1 mg–3 mg daily, reconstitution to 16.7 mg/mL, injection frequency, and protocol. For research use only.
View protocolAOD-9604 dosage chart for the 2 mg Vial: typical dose 300 mcg–500 mcg daily, reconstitution to 0.667 mg/mL, and protocol. For research use only.
View protocolAOD-9604 dosage chart for the 5 mg Vial: typical dose 300 mcg–500 mcg daily, reconstitution to 1.667 mg/mL, and protocol. For research use only.
View protocolAra-290 dosage chart for the 16 mg Vial: typical dose 2 mg–4 mg daily, reconstitution to 8 mg/mL, injection frequency, and protocol. For research use only.
View protocolBPC-157 dosage chart for the 10 mg Vial: typical dose 200 mcg–600 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolBPC-157 dosage chart for the 5 mg Vial: typical dose 200 mcg–600 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolCagrilintide dosage chart (10 mg Vial): dose 600 mcg–4.5 mg weekly, reconstitution 3.33 mg/mL, and injection protocol. For research use only.
View protocolCagrilintide dosage chart (5 mg Vial): dose 600 mcg–4.5 mg weekly, reconstitution 1.67 mg/mL, and injection protocol. For research use only.
View protocolCartalax dosage chart for the 20 mg Vial: typical dose 2 mg–5 mg daily, reconstitution to 6.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolCerebrolysin dosage chart for the 60 mg Vial: typical dose 20 mg–32 mg daily, reconstitution to 20 mg/mL, and protocol. For research use only.
View protocolChonluten dosage chart for the 20 mg Vial: typical dose 250 mcg–4 mg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolCJC-1295 DAC dosage chart for the 2 mg Vial: typical dose 2 mg weekly, reconstitution to 2.0 mg/mL, injection frequency, and protocol. For research use only.
View protocolCJC-1295 DAC dosage chart for the 5 mg Vial: typical dose 300 mcg–1 mg weekly, reconstitution to 2.5 mg/mL, and protocol. For research use only.
View protocolCJC-1295 NO DAC dosage chart for the 5 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolCortagen dosage chart for the 20 mg Vial: typical dose 1 mg–2 mg daily, reconstitution to 6.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolDSIP dosage chart (10 mg Vial): dose 100 mcg–300 mcg daily, reconstitution 3.33 mg/mL, and injection protocol. For research use only.
View protocolDSIP dosage chart for the 5 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 1.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolEpitalon dosage chart for the Epithalon: typical dose 5 mg daily, reconstitution to 5 mg/mL, injection frequency, and protocol. For research use only.
View protocolFOXO4-DRI dosage chart for the 10 mg Vial: typical dose 250 mcg–500 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolGHK-Cu dosage chart for the 100 mg Vial: typical dose 1 mg–2 mg daily, reconstitution to 33.3 mg/mL, injection frequency, and protocol. For research use only.
View protocolGHK-Cu dosage chart (50 mg Vial): dose 1 mg–2 mg 5 days/week, reconstitution 16.67 mg/mL, and injection protocol. For research use only.
View protocolGHRP-2 dosage chart for the 10 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolGHRP-2 dosage chart for the 5 mg Vial: typical dose 100 mcg–200 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolGHRP-6 dosage chart for the 10 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolGHRP-6 dosage chart for the 2 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 0.67 mg/mL, and protocol. For research use only.
View protocolGHRP-6 dosage chart for the 5 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolGlutathione dosage chart for the 600 mg Vial: typical dose 100 mg–200 mg daily, reconstitution to 300 mg/mL, and protocol. For research use only.
View protocolGonadorelin dosage chart for the 2 mg Vial: typical dose 50 mcg–150 mcg weekly, reconstitution to 1 mg/mL, and protocol. For research use only.
View protocolHCG dosage chart for the 5000 IU Vial: typical dose 500 IU weekly, injection frequency, and protocol. For research use only.
View protocolHGH 191AA dosage chart for the 10IU Vial: typical dose 200 mcg–900 mcg daily, reconstitution to 1.11 mg/mL, and protocol. For research use only.
View protocolHMG dosage chart for the 0.15 mg / 75 IU Vial: typical dose 75 IU weekly, injection frequency, and protocol. For research use only.
View protocolIGF-1 LR3 dosage chart for the 1 mg Vial: typical dose 20 mcg–50 mcg daily, reconstitution to 0.333 mg/mL, and protocol. For research use only.
View protocolIpamorelin dosage chart for the 10 mg Vial: typical dose 100 mcg–250 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolIpamorelin dosage chart for the 5 mg Vial: typical dose 100 mcg–250 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolKisspeptin dosage chart for the 10 mg Vial: typical dose 100 mcg–200 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolKPV dosage chart for the 10 mg Vial: typical dose 200 mcg–500 mcg daily, reconstitution to 3.33 mg/mL, injection frequency, and protocol. For research use only.
View protocolL-Carnitine dosage chart for the 200 mg Vial: typical dose 50 mg–100 mg daily, reconstitution to 100 mg/mL, and protocol. For research use only.
View protocolLivagen dosage chart for the 20 mg Vial: typical dose 500 mcg–2 mg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolLL-37 dosage chart for the 5 mg Vial: typical dose 50 mcg–400 mcg daily, reconstitution to 1.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolMazdutide dosage chart for the 10 mg Vial: typical dose 2.5 mg–5 mg weekly, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolMazdutide dosage chart for the 5 mg Vial: typical dose 2.5 mg–5 mg weekly, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolMelanotan II dosage chart for the 10 mg Vial: typical dose 250 mcg–1 mg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolMGF dosage chart for the 5 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 1.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolMOTS-C dosage chart for the 10 mg Vial: typical dose 200 mcg–1 mg daily, reconstitution to 3.33 mg/mL, injection frequency, and protocol. For research use only.
View protocolMOTS-C dosage chart for the 20 mg Vial: typical dose 200 mcg–1 mg daily, reconstitution to 6.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolMOTS-C dosage chart (40 mg Vial): dose 200 mcg–1 mg daily, reconstitution 13.33 mg/mL, and injection protocol. For research use only.
View protocolMOTS-C dosage chart for the 5 mg Vial: typical dose 500 mcg–2 mg daily, reconstitution to 1.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolNAD+ dosage chart for the 1000 mg Vial: typical dose 50 mg–100 mg daily, reconstitution to 333.3 mg/mL, and protocol. For research use only.
View protocolNAD+ dosage chart for the 500 mg Vial: typical dose 50 mg–100 mg daily, reconstitution to 166.7 mg/mL, injection frequency, and protocol. For research use only.
View protocolOvagen dosage chart for the 20 mg Vial: typical dose 10 mcg–150 mcg daily, reconstitution to 10 mg/mL, injection frequency, and protocol. For research use only.
View protocolOxytocin dosage chart (10 mg Vial): dose 100 mcg–500 mcg daily, reconstitution 3.33 mg/mL, and injection protocol. For research use only.
View protocolOxytocin dosage chart (5 mg Vial): dose 100 mcg–500 mcg daily, reconstitution 1.67 mg/mL, and injection protocol. For research use only.
View protocolPE-22-28 dosage chart for the 10 mg Vial: typical dose 50 mcg–200 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolPEG MGF dosage chart for the 2 mg Vial: typical dose 200 mcg–500 mcg daily, reconstitution to 0.667 mg/mL, and protocol. For research use only.
View protocolPinealon dosage chart for the 20 mg Vial: typical dose 1 mg–2 mg daily, reconstitution to 6.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolPNC-27 dosage chart for the 30 mg Vial: typical dose 100 mcg–500 mcg daily, reconstitution to 10 mg/mL, and protocol. For research use only.
View protocolProstamax dosage chart for the 20 mg Vial: typical dose 500 mcg–1 mg daily, reconstitution to 10 mg/mL, and protocol. For research use only.
View protocolPT-141 dosage chart for the 10 mg Vial: typical dose 500 mcg–1.5 mg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolRetatrutide dosage chart (10 mg Vial): dose 2 mg–8 mg weekly, reconstitution 10.0 mg/mL, and injection protocol. For research use only.
View protocolRetatrutide dosage chart (20 mg Vial): dose 2 mg–8 mg weekly, reconstitution 10.0 mg/mL, and injection protocol. For research use only.
View protocolRetatrutide dosage chart (30 mg Vial): dose 2 mg–8 mg weekly, reconstitution 10.0 mg/mL, and injection protocol. For research use only.
View protocolRetatrutide dosage chart (5 mg Vial): dose 2 mg–8 mg weekly, reconstitution 5.0 mg/mL, and injection protocol. For research use only.
View protocolSelank dosage chart for a 10 mg vial with 5 mL and 10 mL nasal spray calculations, supplies, preparation steps, actuator math, and cited human research.
View protocolSelank dosage chart for a 5 mg vial with 5 mL and 10 mL nasal spray calculations, supplies, preparation steps, actuator math, and cited human research.
View protocolSemaglutide dosage chart for the 10 mg Vial: typical dose 250 mcg–2.4 mg weekly, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolSemaglutide dosage chart for the 20 mg Vial: typical dose 250 mcg–2.4 mg weekly, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolSemaglutide dosage chart for the 5 mg Vial: typical dose 250 mcg–2.4 mg weekly, reconstitution to 2.5 mg/mL, and protocol. For research use only.
View protocolSemax dosage chart for a 10 mg vial with 5 mL and 10 mL nasal spray calculations, supplies, preparation steps, actuator math, and cited human research.
View protocolSemax dosage chart for a 5 mg vial with 5 mL and 10 mL nasal spray calculations, supplies, preparation steps, actuator math, and cited human research.
View protocolSermorelin dosage chart for the 10 mg Vial: typical dose 200 mcg–500 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolSermorelin dosage chart for the 5 mg Vial: typical dose 200 mcg–500 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolSLU-PP-332 dosage chart for the 5 mg Vial: typical dose 1.25 mg–2.5 mg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolSNAP-8 dosage guide for a 10 mg vial with topical cream and serum concentration calculations, supplies, preparation math, and cited human research.
View protocolSS-31 dosage chart for the 10 mg Vial: typical dose 5 mg–10 mg daily, reconstitution to 10 mg/mL, injection frequency, and protocol. For research use only.
View protocolSS-31 dosage chart for the 30 mg Vial: typical dose 5 mg–10 mg daily, reconstitution to 10 mg/mL, injection frequency, and protocol. For research use only.
View protocolSS-31 dosage chart for the 50 mg Vial: typical dose 5 mg–10 mg daily, reconstitution to 16.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolSurvodutide dosage chart for the 10 mg Vial: typical dose 600 mcg–6 mg weekly, reconstitution to 5 mg/mL, and protocol. For research use only.
View protocolTB-500 dosage chart for the 10 mg Vial: typical dose 500 mcg–1 mg daily, reconstitution to 3.33 mg/mL, injection frequency, and protocol. For research use only.
View protocolTB-500 dosage chart for the 5 mg Vial: typical dose 500 mcg–1 mg daily, reconstitution to 1.67 mg/mL, injection frequency, and protocol. For research use only.
View protocolTesamorelin dosage chart (10 mg Vial): dose 1 mg–2 mg daily, reconstitution 3.33 mg/mL, and injection protocol. For research use only.
View protocolTesamorelin dosage chart (20 mg Vial): dose 1 mg–2 mg daily, reconstitution 6.67 mg/mL, and injection protocol. For research use only.
View protocolTesamorelin dosage chart for the 5 mg Vial: typical dose 1 mg–2 mg daily, reconstitution to 2.0 mg/mL, injection frequency, and protocol. For research use only.
View protocolTestagen dosage chart for the 20 mg Vial: typical dose 100 mcg–300 mcg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolThymosin Alpha-1 dosage chart for the 10 mg Vial: typical dose 300 mcg–500 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolThymosin Alpha-1 dosage chart for the 5 mg Vial: typical dose 300 mcg–500 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.
View protocolTirzepatide dosage chart for the 10 mg Vial: typical dose 2.5 mg–10 mg weekly, reconstitution to 5.0 mg/mL, and protocol. For research use only.
View protocolTirzepatide dosage chart for the 15 mg Vial: typical dose 2.5 mg–10 mg weekly, reconstitution to 7.5 mg/mL, and protocol. For research use only.
View protocolTirzepatide dosage chart for the 30 mg Vial: typical dose 2.5 mg–10 mg weekly, reconstitution to 10.0 mg/mL, and protocol. For research use only.
View protocolTirzepatide dosage chart for the 5 mg Vial: typical dose 2.5 mg–10 mg weekly, reconstitution to 2.5 mg/mL, and protocol. For research use only.
View protocolVesugen dosage chart for the Lys-Glu-Asp: typical dose 500 mcg–2 mg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolVilon dosage chart for the 20 mg Vial: typical dose 67 mcg–667 mcg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolAOD-9604 + CJC-1295 + Ipamorelin dosage chart for the 12 mg Blend: typical dose 200 mcg–400 mcg daily, reconstitution to 4 mg/mL, and protocol.
View protocolBPC-157 + TB-500 dosage chart for the 10 mg Blend: typical dose 600 mcg–800 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolBPC-157 + TB-500 dosage chart for the 20 mg Blend: typical dose 250 mcg–500 mcg daily, reconstitution to 6.67 mg/mL, and protocol. For research use only.
View protocolCagrilintide + Semaglutide dosage chart for the 10 mg Blend: typical dose 250 mcg–2.4 mg weekly, reconstitution to 3.33 mg/mL, and protocol.
View protocolCJC-1295 + GHRP-2 dosage chart for the 10 mg Blend: typical dose 150 mcg–300 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
View protocolCJC-1295 NO DAC + Ipamorelin dosage chart for the 10 mg Blend: typical dose 100 mcg–300 mcg daily, reconstitution to 3.33 mg/mL, and protocol.
View protocolGLOW dosage chart for the 70 mg Blend: typical dose 2.33 mg daily, reconstitution to 23.3 mg/mL, injection frequency, and protocol. For research use only.
View protocolKLOW dosage chart for the 80 mg Blend: typical dose 250 mcg–750 mcg daily, reconstitution to 26.7 mg/mL, and protocol. For research use only.
View protocolNeuroxelin dosage chart for the 48 mg Vial: typical dose 500 mcg–750 mcg daily, reconstitution to 16 mg/mL, and protocol. For research use only.
View protocolTesamorelin 5mg + Ipamorelin 5mg dosage chart for the 10mg Blend: typical dose 125 mcg–1 mg daily, reconstitution to 3.33 mg/mL, and protocol.
View protocolTri-Heal dosage chart for the 45 mg Blend: typical dose 500 mcg–2 mg daily, reconstitution to 15 mg/mL, and protocol. For research use only.
View protocolCJC-1295 DAC + Ipamorelin stack dosage chart for 2 mg and 5 mg vials, with reconstitution math, injection units, timing, and a research protocol.
View protocolCJC-1295 DAC + Ipamorelin stack dosage chart for separate 5 mg vials, with reconstitution math, injection units, timing, and a research protocol.
View protocolPT-141 + Melanotan II stack dosage chart for separate 10 mg vials, with reconstitution math, injection units, timing, and a research protocol.
View protocolTB-500 + BPC-157 stack dosage chart for separate 5 mg vials, with reconstitution math, injection units, timing, and a research protocol.
View protocol